Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam Vasudevan Nampoothiri, Deepesh Lad, Kripa Shanker Kasudhan et al.|Bone Marrow Transplantation|2019Cited by 19
<scp>Glucagon‐like peptide</scp> ‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysisMuhammad Aaqib Shamim, Kamlesh Khunti, Ravindra Shukla et al.|Diabetes Obesity and Metabolism|2024Cited by 18
PeRinatal, neOnatal, and Maternal OuTcomEs with azithromycin prophylaxis in pregnancy and labour (PROMOTE-PROPHYLAXIS): systematic review and meta-analysisMuhammad Aaqib Shamim, Pradeep Dwivedi, Jogender Kumar et al.|EClinicalMedicine|2024Cited by 14
Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory studyKripa Shanker Kasudhan, Deepesh Lad, Amol Patil et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 9
Effect of Postmeal Fast-Acting Insulin Aspart Injection on the Frequency of Hypoglycemia among Pre-School Children with Type 1 Diabetes: An Open-Label, Cross-Over, Randomized Control TrialArti Yadav, Amol Patil, Rakesh Kumar et al.|The Indian Journal of Pediatrics|2023Cited by 2